377 related articles for article (PubMed ID: 15686598)
1. The progressive nature of Wallerian degeneration in wild-type and slow Wallerian degeneration (WldS) nerves.
Beirowski B; Adalbert R; Wagner D; Grumme DS; Addicks K; Ribchester RR; Coleman MP
BMC Neurosci; 2005 Feb; 6():6. PubMed ID: 15686598
[TBL] [Abstract][Full Text] [Related]
2. Intra-axonal calcium changes after axotomy in wild-type and slow Wallerian degeneration axons.
Adalbert R; Morreale G; Paizs M; Conforti L; Walker SA; Roderick HL; Bootman MD; Siklós L; Coleman MP
Neuroscience; 2012 Dec; 225():44-54. PubMed ID: 22960623
[TBL] [Abstract][Full Text] [Related]
3. Demyelination can proceed independently of axonal degradation during Wallerian degeneration in wlds mice.
Takada H; Yuasa S; Araki T
Eur J Neurosci; 2011 Aug; 34(4):531-7. PubMed ID: 21749497
[TBL] [Abstract][Full Text] [Related]
4. Quantification of the mononuclear phagocyte response to Wallerian degeneration of the optic nerve.
Lawson LJ; Frost L; Risbridger J; Fearn S; Perry VH
J Neurocytol; 1994 Dec; 23(12):729-44. PubMed ID: 7897440
[TBL] [Abstract][Full Text] [Related]
5. Local axonal protection by WldS as revealed by conditional regulation of protein stability.
Wang JT; Medress ZA; Vargas ME; Barres BA
Proc Natl Acad Sci U S A; 2015 Aug; 112(33):10093-100. PubMed ID: 26209654
[TBL] [Abstract][Full Text] [Related]
6. The slow Wallerian degeneration gene, WldS, inhibits axonal spheroid pathology in gracile axonal dystrophy mice.
Mi W; Beirowski B; Gillingwater TH; Adalbert R; Wagner D; Grumme D; Osaka H; Conforti L; Arnhold S; Addicks K; Wada K; Ribchester RR; Coleman MP
Brain; 2005 Feb; 128(Pt 2):405-16. PubMed ID: 15644421
[TBL] [Abstract][Full Text] [Related]
7. The WldS gene delays axonal but not somatic degeneration in a rat glaucoma model.
Beirowski B; Babetto E; Coleman MP; Martin KR
Eur J Neurosci; 2008 Sep; 28(6):1166-79. PubMed ID: 18783366
[TBL] [Abstract][Full Text] [Related]
8. Quantitative and qualitative analysis of Wallerian degeneration using restricted axonal labelling in YFP-H mice.
Beirowski B; Berek L; Adalbert R; Wagner D; Grumme DS; Addicks K; Ribchester RR; Coleman MP
J Neurosci Methods; 2004 Mar; 134(1):23-35. PubMed ID: 15102500
[TBL] [Abstract][Full Text] [Related]
9. Tenascin-C expression during wallerian degeneration in C57BL/Wlds mice: possible implications for axonal regeneration.
Fruttiger M; Schachner M; Martini R
J Neurocytol; 1995 Jan; 24(1):1-14. PubMed ID: 7539482
[TBL] [Abstract][Full Text] [Related]
10. The Wlds transgene reduces axon loss in a Charcot-Marie-Tooth disease 1A rat model and nicotinamide delays post-traumatic axonal degeneration.
Meyer zu Horste G; Miesbach TA; Muller JI; Fledrich R; Stassart RM; Kieseier BC; Coleman MP; Sereda MW
Neurobiol Dis; 2011 Apr; 42(1):1-8. PubMed ID: 21168501
[TBL] [Abstract][Full Text] [Related]
11. Persistence of neuromuscular junctions after axotomy in mice with slow Wallerian degeneration (C57BL/WldS).
Ribchester RR; Tsao JW; Barry JA; Asgari-Jirhandeh N; Perry VH; Brown MC
Eur J Neurosci; 1995 Jul; 7(7):1641-50. PubMed ID: 7551190
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms of axonal spheroid formation in central nervous system Wallerian degeneration.
Beirowski B; Nógrádi A; Babetto E; Garcia-Alias G; Coleman MP
J Neuropathol Exp Neurol; 2010 May; 69(5):455-72. PubMed ID: 20418780
[TBL] [Abstract][Full Text] [Related]
13. The WldS protein protects against axonal degeneration: a model of gene therapy for peripheral neuropathy.
Wang MS; Fang G; Culver DG; Davis AA; Rich MM; Glass JD
Ann Neurol; 2001 Dec; 50(6):773-9. PubMed ID: 11761475
[TBL] [Abstract][Full Text] [Related]
14. Wlds protection distinguishes axon degeneration following injury from naturally occurring developmental pruning.
Hoopfer ED; McLaughlin T; Watts RJ; Schuldiner O; O'Leary DD; Luo L
Neuron; 2006 Jun; 50(6):883-95. PubMed ID: 16772170
[TBL] [Abstract][Full Text] [Related]
15. Deletion of SIRPα (signal regulatory protein-α) promotes phagocytic clearance of myelin debris in Wallerian degeneration, axon regeneration, and recovery from nerve injury.
Elberg G; Liraz-Zaltsman S; Reichert F; Matozaki T; Tal M; Rotshenker S
J Neuroinflammation; 2019 Dec; 16(1):277. PubMed ID: 31883525
[TBL] [Abstract][Full Text] [Related]
16. Axonal involvement in the Wlds neuroprotective effect: analysis of pure motoneurons in a mouse model protected from motor neuron disease at a pre-symptomatic age.
Simonin Y; Perrin FE; Kato AC
J Neurochem; 2007 Apr; 101(2):530-42. PubMed ID: 17402973
[TBL] [Abstract][Full Text] [Related]
17. Over-expression of alpha-synuclein in the nervous system enhances axonal degeneration after peripheral nerve lesion in a transgenic mouse strain.
Siebert H; Kahle PJ; Kramer ML; Isik T; Schlüter OM; Schulz-Schaeffer WJ; Brück W
J Neurochem; 2010 Aug; 114(4):1007-18. PubMed ID: 20524960
[TBL] [Abstract][Full Text] [Related]
18. WldS and PGC-1α regulate mitochondrial transport and oxidation state after axonal injury.
O'Donnell KC; Vargas ME; Sagasti A
J Neurosci; 2013 Sep; 33(37):14778-90. PubMed ID: 24027278
[TBL] [Abstract][Full Text] [Related]
19. NAD and axon degeneration: from the Wlds gene to neurochemistry.
Wang J; He Z
Cell Adh Migr; 2009; 3(1):77-87. PubMed ID: 19372760
[TBL] [Abstract][Full Text] [Related]
20. The neuroprotective factor Wlds does not attenuate mutant SOD1-mediated motor neuron disease.
Vande Velde C; Garcia ML; Yin X; Trapp BD; Cleveland DW
Neuromolecular Med; 2004; 5(3):193-203. PubMed ID: 15626820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
